社会不安障害(SAD)治療のグローバル臨床試験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Social Anxiety Disorders (SAD) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Social Anxiety Disorders (SAD) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Social Anxiety Disorders (SAD) 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Social Anxiety Disorders (SAD) Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
H. Lundbeck A/S 34
Clinical Trial Overview of H. Lundbeck A/S 34
Bluefish Pharmaceuticals AB 35
Clinical Trial Overview of Bluefish Pharmaceuticals AB 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Teva Pharmaceutical Industries Limited 38
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 38
Pherin Pharmaceuticals, Inc. 39
Clinical Trial Overview of Pherin Pharmaceuticals, Inc. 39
Clinical Trial Overview of Top Institutes / Government 40
Massachusetts General Hospital 40
Clinical Trial Overview of Massachusetts General Hospital 40
Duke University 41
Clinical Trial Overview of Duke University 41
Medical University of South Carolina 42
Clinical Trial Overview of Medical University of South Carolina 42
START Clinic for Mood and Anxiety Disorders 43
Clinical Trial Overview of START Clinic for Mood and Anxiety Disorders 43
Boston University 44
Clinical Trial Overview of Boston University 44
Drexel University 45
Clinical Trial Overview of Drexel University 45
University of California, San Diego 46
Clinical Trial Overview of University of California, San Diego 46
Emory University 47
Clinical Trial Overview of Emory University 47
University of California, Los Angeles 48
Clinical Trial Overview of University of California, Los Angeles 48
San Diego State University 49
Clinical Trial Overview of San Diego State University 49
Five Key Clinical Profiles 50
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 74


【レポート販売概要】

■ タイトル:社会不安障害(SAD)治療のグローバル臨床試験動向(2014年下半期)
■ 英文:Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC2276CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。